1-3 of 3
Anna D. Schaal, ARNP
Close
Sort by
Journal Articles

Pilot Study of Low Dose Melphalan and Bortezomib for Treatment of Acute Myelogenous Leukemia and High-Risk Myelodysplastic Syndromes.

Jeffrey A. Bubis, DO, Pamela Ely, MD, PhD, Kenneth R. Meehan, MD, Diane Stearns, ARNP, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Christopher Lowrey, MD, Elizabeth M. Bengtson, MD, John Hill, MD, Marc Gautier, MD
Journal: Blood
Blood (2005) 106 (11): 4633.
https://doi.org/10.1182/blood.V106.11.4633.4633
Published: 2005
Journal Articles

Successful PBSC Mobilization, Collection, Transplantation and Engraftment after Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan for Non-Hodgkin’s Lymphoma (NHL).

Pamela Ely, MD, PhD, Diane M. Stearns, ARNP, Bassem I. Zaki, MD, Thomas F. Fitzmaurice, Ph.D, Marc Gautier, MD, Christopher H. Lowrey, MD, Elizabeth M. Bengtson, MD, John M. Hill, MD, Anna D. Schaal, ARNP, Elizabeth A. Kimtis, ARNP, Lynn Root, RN, Susan Webber, MT (ASCP), BB, Zbigniew M. Szczepiorkowski, MD, Ph.D, Kenneth R. Meehan, MD
Journal: Blood
Blood (2005) 106 (11): 5517.
https://doi.org/10.1182/blood.V106.11.5517.5517
Published: 2005
Journal Articles

Subcutaneous Administration of Alemtuzumab: A Single Institution Experience.

Jeffrey A. Bubis, DO, Anna D. Schaal, ARNP, Elizbeth A. Kimtis, ARNP, Marc Gautier, MD
Journal: Blood
Blood (2005) 106 (11): 5029.
https://doi.org/10.1182/blood.V106.11.5029.5029
Published: 2005